Table 1 Associations of PSGR expression with clinicopathological characteristics of PCa
| PSGR | ||
|---|---|---|
| Mean ± SE | P | |
| Age (years) | ||
| ≤ 61 (n = 72) | 130.90 ± 6.72 | 0.95 |
| > 61 (n = 78) | 131.40 ± 6.03 | |
| Tumor stage | ||
| T2a (n = 26) | 146.60 ± 11.90 | 0.33 |
| T2b (n = 39) | 127.61 ± 8.06 | |
| T2c (n = 48) | 124.21 ± 7.74 | |
| T3+ (n = 37) | 132.80 ± 7.52 | |
| Lymphovascular invasion | ||
| Present (n = 66) | 125.30 ± 6.51 | 0.19 |
| Absent (n = 84) | 136.72 ± 5.87 | |
| Extraprostatic extension | ||
| Present (n = 65) | 135.10 ± 6.99 | 0.83 |
| Absent (n = 85) | 132.90 ± 6.67 | |